Zyvox (linezolid), a potent new antibiotic for certain resistant gram-positive infections
May 2000
The FDA just approved Zyvox (linezolid), a potent new antibiotic for certain resistant gram-positive infections.
Zyvox is the first in a new class...oxazolidinones. It works by inhibiting bacterial protein synthesis.
It will be used for certain gram-positive infections...including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE).
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote